Therapeutics, Inc Stock Performance
as on October 21, 2025 at 1:29 am IST
Day's Low
Day's High
$36.1$39.01
0.66%
Downside
7.35%
Upside
52 Week's Low
52 Week's High
$16.54$50.454.50%
Downside
38.69%
Upside
Therapeutics, Inc share price movements today
- Previous Close
- $38.26
- Open
- $38.87
- Volume
- 1.3M
- Day's Low - High
- $36.1 - $39.01
- 52 Week Low - High
- $16.54 - $50.4
Therapeutics, Inc Historical Returns
- 1 Month Return
- -9.49 %
- 3 Month Return
- + 13.43 %
- 1 Year Return
- + 36.69 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Therapeutics, Inc Stock Fundamentals & Key Indicators
Check Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-2.5491
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-61.9M
Revenue (TTM)
5.0M
Profit Margin
0.00%
Return On Equity TTM
121808100.00%
Therapeutics, Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Therapeutics, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | NA | NA | 0.00% | |
| BUY | $63.1B | 240.52% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $106.9B | 94.28% | 29.67 | 31.86% | |
| BUY | $61.3B | 0.25% | 14.58 | 31.37% |
Stock Returns calculator for Therapeutics, Inc Stock including INR - Dollar returns
The Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Therapeutics, Inc investment value today
Current value as on today
₹1,34,562
Returns
₹34,562
(+34.56%)
Returns from Therapeutics, Inc Stock
₹29,832 (+29.83%)
Dollar Returns*
₹4,730 (+4.73%)
Analyst Recommendation on Therapeutics, Inc Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Therapeutics, Inc. Average target price of $53
Therapeutics, Inc Share Price Target
Get share price movements and forecasts by analysts on Therapeutics, Inc.
What analysts predicted
31.43%UPSIDE
Target Price
$53
Current Price
$36.34
Analyzed by
10 Analysts
Target
$53.00
Therapeutics, Inc target price $53, a slight upside of 31.43% compared to current price of $36.34. According to 10 analysts rating.
Therapeutics, Inc Stock’s Investor Sentiment and Interest
Search interest for Therapeutics, Inc Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Therapeutics, Inc Quarterly Profit & Loss
All numbers in Millions USD
Therapeutics, Inc Annual Profit & Loss
All numbers in Millions USD
Therapeutics, Inc Quarterly Cash Flow
All numbers in Millions USD
Therapeutics, Inc Annual Cash Flow
All numbers in Millions USD
Therapeutics, Inc News & Key Events
Today's Timeline - 30 September
Tue, 07:04 PM
-Lenz Therapeutics announces VIZZ eye drops are now available in the U.S. for presbyopia treatment.
Insights on Therapeutics, Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, LENZ stock has moved up by 60.6%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 26.1%
About Therapeutics, Inc
| Organisation | Therapeutics, Inc |
| Headquarters | 201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075 |
| CEO | Mr. Evert B. Schimmelpennink |
| E-voting on shares | Click here to vote |
Key Management of Therapeutics, Inc
Name | Title |
|---|---|
Mr. James W. McCollum | Co-Founder & Director |
Mr. Marc G. Odrich M.D. | Chief Medical Officer |
Mr. Domenick Porfidia | Vice President of Sales |
Mr. David Choromanski | Vice President of Marketing |
Mr. Shawn Olsson | Chief Commercial Officer |
Kris Gambelin | Senior Vice President of Regulatory & Clincal Operations |
Mr. Evert B. Schimmelpennink | President, CEO, Secretary & Director |
Ms. Melissa Rosness | Senior Vice President of Manufacturing Operations |
Mr. Daniel R. Chevallard CPA | Chief Financial Officer |
FAQs
What is Therapeutics, Inc share price today?
Therapeutics, Inc share price today is $36.34 as on at the close of the market. Therapeutics, Inc share today touched a day high of $39.01 and a low of $36.1.
What is the 52 week high and 52 week low for Therapeutics, Inc share?
Therapeutics, Inc share touched a 52 week high of $50.4 on and a 52 week low of $16.54 on . Therapeutics, Inc stock price today i.e. is closed at $36.34,which is 27.90% down from its 52 week high and 119.78% up from its 52 week low.
What is Therapeutics, Inc's market capitalisation today?
Therapeutics, Inc market capitalisation is $0.00T as on .
How to invest in Therapeutics, Inc Stock (LENZ) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Therapeutics, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Therapeutics, Inc Shares that will get you 0.0413 shares as per Therapeutics, Inc share price of $36.34 per share as on October 21, 2025 at 1:29 am IST.
What is the minimum amount required to buy Therapeutics, Inc Stock (LENZ) from India?
Indian investors can start investing in Therapeutics, Inc (LENZ) shares with as little as ₹87.9 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Therapeutics, Inc share’s latest price of $36.34 as on October 21, 2025 at 1:29 am IST, you will get 0.2752 shares of Therapeutics, Inc. Learn more about
fractional shares .